INNOVATION:New Hope for Brain Cancer
Anti-psychotic drugs show tumor-killing activity in glioblastoma.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget. Read More